ArticlebioRxiv : the preprint server for biology2026
mSWI/SNF complex inhibition sensitizes KRAS-mutant lung cancers to targeted therapies via epithelial-mesenchymal subversion.
Claudia Gentile et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.